Heart rate response and functional capacity in patients with chronic heart failure with preserved ejection fraction.

about

Heart rate response and functional capacity in patients with chronic heart failure with preserved ejection fraction.

Item

http://www.wikidata.org/entity/Q52382040

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Heart rate response and functi ...... h preserved ejection fraction.

@en

Heart rate response and functi ...... h preserved ejection fraction.

@nl

type

Item

label

Heart rate response and functi ...... h preserved ejection fraction.

@en

Heart rate response and functi ...... h preserved ejection fraction.

@nl

prefLabel

Heart rate response and functi ...... h preserved ejection fraction.

@en

Heart rate response and functi ...... h preserved ejection fraction.

@nl

P1476

Heart rate response and functi ...... th preserved ejection fraction

@en

P2093

Alejandro Bellver

http://www.w3.org/2001/XMLSchema#string

Eduardo Núñez

http://www.w3.org/2001/XMLSchema#string

Eloy Domínguez

http://www.w3.org/2001/XMLSchema#string

Enrique Santas

http://www.w3.org/2001/XMLSchema#string

Francisco J Chorro

http://www.w3.org/2001/XMLSchema#string

Joana Melero

http://www.w3.org/2001/XMLSchema#string

José María Ramón

http://www.w3.org/2001/XMLSchema#string

Julio Núñez

http://www.w3.org/2001/XMLSchema#string

Laura López

http://www.w3.org/2001/XMLSchema#string

P2860

A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation

Association between resting heart rate, chronotropic index, and long-term outcomes in patients with heart failure receiving β-blocker therapy: data from the HF-ACTION trial.

Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction

New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes.

Epidemiology and clinical course of heart failure with preserved ejection fraction

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribut

Chronotropic incompetence: causes, consequences, and management

Exercise testing for chronotropic assessment.

Role of physical training in heart failure with preserved ejection fraction

Association of Chronic Kidney Disease With Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction.

P304

579-585

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EHF2.12281

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Patricia Palau

P577

2018-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29573575

http://www.w3.org/2001/XMLSchema#string

P932

6073018

http://www.w3.org/2001/XMLSchema#string